HOOKIPA Pharma Inc. (HOOK)
NASDAQ: HOOK · Real-Time Price · USD
2.150
-0.150 (-6.52%)
At close: Nov 22, 2024, 4:00 PM
2.110
-0.040 (-1.86%)
After-hours: Nov 22, 2024, 5:48 PM EST

HOOKIPA Pharma Stock Forecast

HOOK's stock price has decreased by -53.25% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 4 analysts with 12-month price forecasts for HOOKIPA Pharma stock have an average target of 38.75, with a low estimate of 23 and a high estimate of 60. The average target predicts an increase of 1,702.33% from the current stock price of 2.15.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $23 $38.75 $48 $60
Change +969.77% +1702.3% +2132.6% +2690.7%

Analyst Ratings

The average analyst rating for HOOKIPA Pharma stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 222221
Buy 123333
Hold 000000
Sell 000000
Strong Sell 000000
Total 345554

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
RBC Capital
RBC Capital
Buy
Maintains
$50$48
Buy Maintains $50$48 +2,132.56% Nov 15, 2024
JMP Securities
JMP Securities
Buy
Maintains
$23$24
Buy Maintains $23$24 +1,016.28% Aug 9, 2024
JMP Securities
JMP Securities
Buy
Maintains
$50$23
Buy Maintains $50$23 +969.77% Jul 26, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$50$60
Strong Buy Maintains $50$60 +2,690.70% Jun 5, 2024
RBC Capital
RBC Capital
Buy
Reiterates
$50
Buy Reiterates $50 +2,225.58% May 21, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
51.40M
from 20.13M
Increased by 155.36%
Revenue Next Year
25.50M
from 51.40M
Decreased by -50.39%
EPS This Year
-2.30
from -8.63
EPS Next Year
-5.53
from -2.30
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
11.94M19.58M18.45M14.25M20.13M51.40M25.50M2.55M
Revenue Growth
56.53%63.99%-5.80%-22.76%41.27%155.36%-50.39%-90.00%
EPS
-24.10-16.93-23.04-9.91-8.63-2.30-5.53-8.45
EPS Growth
--------
Forward PE
--------
No. Analysts -----554
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 61.8M 26.3M 2.6M
Avg 51.4M 25.5M 2.6M
Low 41.1M 24.5M 2.5M

Revenue Growth

Revenue Growth 20242025202620272028
High
207.2%
-48.9%
-89.7%
Avg
155.4%
-50.4%
-90.0%
Low
104.0%
-52.3%
-90.4%

EPS Forecast

EPS 20242025202620272028
High -0.71 -5.00 -8.69
Avg -2.30 -5.53 -8.45
Low -3.76 -5.97 -8.11

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.